Category:
Active Pharmaceutical Ingredients
CAS NO:
N/A
Standard:
EP,
Orlistat Impurity 8 is a critical degradation product and process-related impurity associated with the synthesis of the anti-obesity drug Orlistat. It typically arises from incomplete hydrogenation or side reactions during the manufacturing of the active pharmaceutical ingredient. The molecular formula is C25H47NO6, and it is identified by CAS No. 199702-09-3.
Store in a cool, dry place away from light and moisture. Handle with appropriate PPE to avoid skin contact and inhalation. Strictly controlled usage limits apply in clinical formulations to ensure patient safety.